Cite Score:
0.25
ELSEVIER SCOPUS

Cardiac resynchronisation – a new standard in heart failure therapy

AUTHORS

M Azizi Azizi 1 , H Nägele 2 , *

AUTHORS INFORMATION

1 Albertinen Krankenhaus, Herzzentrum, Süntelstr. 11a, 22457 Hamburg, Germany

2 Krankenhaus Reinbek, St. Adolf-Stift, Medizinische Klinik, Hamburgerstr. 41, 21465 Reinbek, Germany

How to Cite: Azizi M A, Nägele H . Cardiac resynchronisation – a new standard in heart failure therapy, Int Cardio Res J. 2018 ; 1(3):e74120.

ARTICLE INFORMATION

International Cardiovascular Research Journal: 1 (3); e74120
Published Online: September 30, 2017
Article Type: Editorial
Received: May 22, 2018
Accepted: September 30, 2007

Crossmark

CHEKING

READ FULL TEXT
Abstract

Chronic heart failure is a clinical syndrome and the final common pathway of different cardiac diseases. A rising
incidence is reported all over the world, leading to enormous cost and spending of health care resources.
Although medical therapy with beta blockers, ACE-inhibitors and spironolactone has proved to be efficacious,
mortality remains high. Therefore the introduction of supplemental methods is very welcome and indeed, electrical
therapies with implanted devices become increasingly important in this regard. Besides the implanted
cardioverter defibrillator (ICD), cardiac resynchronisation therapy (CRT) has recently been shown not only to
improve exercise tolerance, but also to prolong survival in patients with heart failure and cardiac asynchrony.
Therefore, an overview of cardiac resynchronisation therapy, including additional CRT-ICD capabilities, is
given herein according the literature. This includes current guidelines, our own implantation experience, and
follow-up data of 500 patients during 1999 – 2007.

Keywords

a

© 0, Shiraz University of Medical Sciences.

Fulltext

The full text is available in PDF.

References

  • 1. The references are available in PDF.
  • COMMENTS

    LEAVE A COMMENT HERE: